Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease

17 Mar 2003

Abstract excerpt

Anaplastic large cell lymphoma (ALCL) with t(2;5)(p23;q35) and Hodgkin disease (HD) share many cellular features, including expression of CD30. We compared gene expression profiles of 4 ALCL (Karpas 299, SU-DHL-1, DEL, SR-786) and 3 HD cell lines and found that BCL3, which encodes a nuclear protein belonging to the I kappa B family of inhibitors of nuclear factor-kappa B (NF-kappa B) transcriptional factors, was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Lymphoma Diagnosis and Treatment
Share to NF-κB Signaling Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12456498
DOI: 10.1182/blood-2002-08-2464

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin diseasePMID 12456498Read ↗

Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.Semantic proximity Read ↗

Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphomaSemantic proximity Read ↗

Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity.Semantic proximity Read ↗

A Novel B-cell Line (U-2932) Established from a Patient with Diffuse Large B-cell Lymphoma Following Hodgkin LymphomaSemantic proximity Read ↗

Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of ageSemantic proximity Read ↗

Translocations involving anaplastic lymphoma kinase (ALK).Semantic proximity Read ↗

Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns?Semantic proximity Read ↗

Primary systemic anaplastic large-cell lymphoma (CD30+): advances in biology and current therapeutic approaches.Semantic proximity Read ↗

The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive LymphomasSemantic proximity Read ↗

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomesSemantic proximity Read ↗

Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients.Semantic proximity Read ↗

Anaplastic large cell lymphoma: a clinicopathologic study of 53 patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.